Ceftin and Cefzil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ceftin (cefuroxime axetil) and Cefzil (cefprozil). Common drug interactions include abdominal discomfort among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Ceftin and Cefzil. It is created by eHealthMe based on reports of 53 people who take the same drugs from the FDA, and is updated regularly.

What is Ceftin?

Ceftin has active ingredients of cefuroxime axetil. It is often used in sinusitis. eHealthMe is studying from 4,333 Ceftin users. Check the latest studies of Ceftin.

What is Cefzil?

Cefzil has active ingredients of cefprozil. It is often used in sinusitis. eHealthMe is studying from 1,106 Cefzil users. Check the latest studies of Cefzil.



On Jul, 10, 2026

53 people who take Ceftin and Cefzil together, and have interactions are studied.

Ceftin and Cefzil drug interactions.

What are the common drug interactions of Ceftin and Cefzil, by gender? *:

female:

  1. Abdominal discomfort
  2. Abdominal pain
  3. Atelectasis (partial or complete collapse of the lung)
  4. Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
  5. Cardiomegaly (increased size of heart than normal)
  6. Cholecystitis chronic (long lasting infection of gallbladder)
  7. Cholesterosis (abnormal deposition of cholesterol in tissues)
  8. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  9. Diarrhoea
  10. Faeces discoloured

male:

  1. Anxiety
  2. Adenoma benign (non-cancerous tumour -secreting)
  3. Cough
  4. Diabetic retinopathy (damage to the retina caused by complications of diabetes)
  5. Dizziness
  6. Dyspnoea (difficult or laboured respiration)
  7. Ear disorder
  8. Flushing (the warm, red condition of human skin)
  9. Groin pain
  10. Intervertebral disc displacement

What are the common drug interactions of Ceftin and Cefzil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Brain injury
  4. Death
  5. Emotional distress
  6. Fear
  7. Injury
  8. Multi-organ failure (multisystem organ failure)
  9. Pain
  10. Renal failure (kidney dysfunction)

10-19:

  1. Back pain
  2. Neutropenia (an abnormally low number of neutrophils)
  3. Pyrexia (fever)
  4. Drug hypersensitivity
  5. Rash pruritic (redness with itching)
  6. Escherichia urinary tract infection (urinary tract infection by escherichia coli)
  7. Viral infection
  8. Amenorrhoea (absence of a menstrual period in a woman of reproductive age)
  9. Menometrorrhagia (a condition in which prolonged or excessive uterine bleeding occurs irregularly and more frequently than normal)
  10. Pruritus (severe itching of the skin)

20-29:

  1. Abdominal discomfort
  2. Abdominal pain
  3. Abdominal pain upper
  4. Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
  5. Cholecystitis chronic (long lasting infection of gallbladder)
  6. Cholesterosis (abnormal deposition of cholesterol in tissues)
  7. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  8. Diarrhoea
  9. Faeces discoloured
  10. Hypokalaemia (low potassium)

30-39:

  1. Anaemia (lack of blood)
  2. Asthma
  3. Blood alkaline phosphatase increased
  4. Blood bilirubin increased
  5. Blood lactate dehydrogenase increased
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Chronic obstructive airways disease
  8. Drug hypersensitivity
  9. Gamma-glutamyltransferase increased
  10. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)

40-49:

  1. Lung consolidation (a condition whereby the lung tissues solidify because of the accumulation of solid and liquid material in the air spaces)
  2. Pain
  3. Palpitations (feelings or sensations that your heart is pounding or racing)
  4. Psoriasis (immune-mediated disease that affects the skin)
  5. Pulmonary oedema (fluid accumulation in the lungs)
  6. Rib fracture
  7. Swelling
  8. Abdominal pain upper
  9. Activated partial thromboplastin time prolonged
  10. Activities of daily living impaired

50-59:

  1. Drug hypersensitivity
  2. Chronic kidney disease
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  5. Impaired gastric emptying
  6. Nephrogenic anaemia (anaemia due to kidney disease)
  7. Renal failure (kidney dysfunction)

60+:

  1. Adenoma benign (non-cancerous tumour -secreting)
  2. Aortic valve sclerosis (narrowing of the aortic valve)
  3. Diabetic retinopathy (damage to the retina caused by complications of diabetes)
  4. Dizziness
  5. Dyspnoea (difficult or laboured respiration)
  6. Ear disorder
  7. Flushing (the warm, red condition of human skin)
  8. Groin pain
  9. Intervertebral disc displacement
  10. Mitral valve incompetence (inefficient heart valve)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 15.09%
  2. Asthma: 7 people, 13.21%
  3. Stress And Anxiety: 7 people, 13.21%
  4. Pain: 6 people, 11.32%
  5. High Blood Cholesterol: 6 people, 11.32%
  6. Infection: 6 people, 11.32%
  7. Depression: 5 people, 9.43%
  8. High Blood Pressure: 4 people, 7.55%
  9. Multiple Allergies (allergy to multiple agents): 4 people, 7.55%
  10. Cough: 4 people, 7.55%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftin and Cefzil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ceftin and Cefzil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ceftin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cefzil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ceftin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefzil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on cefuroxime axetil and cefprozil (the active ingredients of Ceftin and Cefzil, respectively), and Ceftin and Cefzil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: